Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts MarketBeat
Cancer in Focus: Merck & Co., Vidac Pharma and AstraZeneca | 2026-08-17 | Investing News Stockhouse
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges CNBC
Merck & Co. (MRK) EVP Richard DeLuca sells 45,320 shares over three days stocktitan.net
Merck & Co. ups sales guidance as newer drugs grow alongside Keytruda FirstWord Pharma
ABN Amro Investment Solutions Has $39.71 Million Stake in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Merit Financial Group LLC MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Gateway Investment Advisers LLC MarketBeat
Mission Wealth Management LP Grows Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Richard Deluca Sells 11,699 Shares of Stock MarketBeat
Envestnet Portfolio Solutions Inc. Acquires 23,240 Shares of Merck & Co., Inc. $MRK MarketBeat
QV Investors Inc. Reduces Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Exchange Traded Concepts LLC Has $14.57 Million Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Moody Lynn Lieberson & Walker LLC MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 245,665 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Jennifer Zachary Sells 80,315 Shares MarketBeat
Merck & Co., Inc. (NYSE:MRK) Reaches New 12-Month High Following Analyst Upgrade MarketBeat
CV Advisors LLC Takes Position in Merck & Co., Inc. $MRK MarketBeat
Novem Group Has $7.20 Million Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Richard Deluca Sells 20,784 Shares of Stock MarketBeat
LS Investment Advisors LLC Has $2.88 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline Business Wire
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells 12,837 Shares of Stock MarketBeat
Argus Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price MarketBeat
Merck & Co., Inc. (NYSE:MRK) Upgraded at Daiwa Securities Group MarketBeat
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells 10,000 Shares of Stock MarketBeat
Handelsbanken Fonder AB Raises Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Generali Investments Management Co LLC MarketBeat
Sapient Capital LLC Lowers Stake in Merck & Co., Inc. $MRK MarketBeat
KMG Fiduciary Partners LLC Sells 26,888 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck Announces Fourth-Quarter 2026 Dividend Business Wire
Carolina Wealth Advisors LLC Sells 15,954 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co Inc (MRK) EVP & President of Merck Animal Health Rich GuruFocus
Merck & Co., Inc. $MRK Shares Sold by Rockland Trust Co. MarketBeat
Merck & Co., Inc. Q2 Earnings Call Highlights MarketBeat
Merck stock trades close to its 12-month high as Q2 2026 growth and Keytruda momentum support the ou AD HOC NEWS
PensionDanmark Pensionsforsikringsaktieselskab Buys 54,260 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck (MRK) animal health chief DeLuca sells 6,050 shares stocktitan.net
What Is Keeping Merck & Co (NYSE:MRK) In The Healthcare Spotlight? Kalkine Media
Merck licenses experimental HIV pill to generic makers in 129 countries Reuters